🇺🇸 FDA
Drug

bortezomib

Brand: BORTEZOMIB

approved

Quick answer

bortezomib (BORTEZOMIB), is a pharmaceutical active ingredient, associated with MAIA Biotechnology, with approved status in the US.

Key facts

INN
bortezomib
Brand
BORTEZOMIB
Route
INJECTION
Formulation
INJECTABLE
Originator
MAIA Biotechnology

Related patents

patent

US 12005069

Bortezomib compositions

Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11752164

Bortezomib compositions

Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11679119

Bortezomib compositions

Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11672813

Bortezomib compositions

Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is bortezomib?

bortezomib (BORTEZOMIB), is a pharmaceutical active ingredient, associated with MAIA Biotechnology, with approved status in the US.

What is the brand name for bortezomib?

BORTEZOMIB is a marketed brand name for bortezomib. Check FDA Drugs@FDA for the current US label holder.